Journal decision profile

Archiv Der Pharmazie

Chemistry · Medicine

Archiv Der Pharmazie's 2026 Journal Metrics Score is 3.7, ranking Q1 in Pharmacology and 1 other subfield. Two-year citation average from OpenAlex data, updated August 2026.

WileyGermanypISSN 0365-6233eISSN 1521-4184
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
3.7

Journal Metrics Score 2026 · 2021–2024 window citedness 3.03.

Review & acceptance time
i
Review & acceptance timeCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED
126 daysmedian

Middle 50%: 92–161 days

100 of 100 PubMed-indexed articles · 100% coverage · 2024–2025

Archiv Der Pharmazie accepts papers a median of 126 days after submission, including peer review and revisions. That is slower than 83% of comparable journals with PubMed timing data.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
$3,300

Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.

Free preview · no sign-in

Does your manuscript fit Archiv Der Pharmazie?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iSubmission-to-acceptanceCalendar days from the received date to the accepted date in recent PubMed records. This includes editorial handling and author revisions, so it is not the time to first decision and not pure peer-review time. The radar uses a 0–100 cohort percentile with shorter observed timing plotted farther out; it does not measure review quality.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
3.72026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#6 / 2,739LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
11%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.90MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
126 daysIQR 92–161 DAYS
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
210 / yr2021–2024 AVG
Field-normalized top 10% share11%

92 of 835 works · same type, year & subfield

Field-normalized top 1% share0.2%

2 works · same type, year & subfield

Median FWCI0.90×

Below field-year expectation

Source output rank#6

of 2,739 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.90, so its typical recent paper runs about 10% below its field benchmark.

What does Top 10% Share mean?

11% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2016–2025

1322016
1152017
1192018
1382019
1882020
1682021
2052022
1972023
2692024
2502025

Recent work-type mix

835 OpenAlex works · 2021–2024

Article87.4%
Paratext11.7%
Erratum0.4%
Editorial0.2%
Review0.2%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Archiv Der Pharmazie publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Synthesis and biological activity170
Enzyme function and inhibition51
Cholinesterase and Neurodegenerative Diseases39
Synthesis and Characterization of Heterocyclic Compounds26
Structural and Chemical Analysis of Organic and Inorganic Compounds22
Computational Drug Discovery Methods19
Synthesis and Biological Evaluation17
Analytical Methods in Pharmaceuticals10
Quinazolinone synthesis and applications10
Multicomponent Synthesis of Heterocycles9
Methodology: OpenAlex snapshot 2026-10-22. FWCI, percentile badges, topics, and type mix use 835 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
Organic ChemistryQ2
PharmacologyQ1
Molecular BiologyQ2
Ecology, Evolution, Behavior and SystematicsQ1
Q1
Subfield Quartile
B3
CAS Block

Ranking and source check

#863
of 3,784 Biology & Basic Science field journals
#828
among Q1 Biology & Basic Science journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
49,139
H-Index
86
Fully Open Access
No
Recent OA Works
14,768
Subject Areas
Organic ChemistryPharmacologyMolecular BiologyEcology, Evolution, Behavior and Systematics

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

Common questions about Archiv Der Pharmazie

What is Archiv Der Pharmazie's Journal Metrics Score in 2026?

Archiv Der Pharmazie's 2026 Journal Metrics Score is 3.7, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What quartile is Archiv Der Pharmazie in?

Archiv Der Pharmazie's best quartile is Q1. By OpenAlex subfield: Q2 in Organic Chemistry; Q1 in Pharmacology; Q2 in Molecular Biology; Q1 in Ecology, Evolution, Behavior and Systematics. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Archiv Der Pharmazie will not match this score exactly. Compare journals using one source at a time.

How long does Archiv Der Pharmazie take to accept a paper?

Archiv Der Pharmazie accepts papers a median of 126 days after submission across 100 recent PubMed records with both dates; the middle half took 92–161 days. This includes peer review, editorial handling, and revisions.

How long is the peer review time at Archiv Der Pharmazie?

PubMed records when a manuscript was received and accepted, not the individual review stages, so peer review time on its own is not available. The full time from submission to acceptance at Archiv Der Pharmazie, which includes peer review and revisions, has a median of 126 days. For the time to a first decision, check the journal's own website.

Is Archiv Der Pharmazie faster than similar journals?

Archiv Der Pharmazie's median of 126 days from submission to acceptance is slower than 83% of comparable journals with PubMed timing data.

How much does it cost to publish in Archiv Der Pharmazie?

OpenAlex lists an indicative article processing charge of $3,300 USD for Archiv Der Pharmazie. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.

Which journals are alternatives to Archiv Der Pharmazie?

Comparable journals include European Journal of Medicinal Chemistry Reports, Medicinal Chemistry Research, Future Medicinal Chemistry, and Medicinal Chemistry. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

Cite an article from this journal
Back to Search